600+ sources. One page. See who else covered it.
The startup has completed enrollment of an early-stage study testing a first-of-its-kind treatment for facioscapulohumeral muscular dystrophy, a disease targeted by many other drugmakers.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
A long-term Singapore ageing study informs a new biological age test.
New alliance places six demands, including Grade-10 status for pharmacists, medical technologists
Perkant Tech has raised Rs 6.6 crore for Abhay Parimiti, a device it says takes an automated health assessment in under 60 seconds, backed by a government innovation fund.
Around 75% of American adults need vision correction, but access to eye care remains uneven, particularly in rural communities and for patients with mobility limitations. To help close those gaps, Dr.
A one-year study tracking high school students suggests addictive use of short-form videos limits teenagers' ability to focus on the future.
Staff at North Devon district hospital given training in difficult births in case mothers-to-be cannot get to Exeter Doctors at one of England’s remotest hospitals have been given a “crash course” in…